InvestorsObserver
×
News Home

Is Ideaya Biosciences Inc (IDYA) a Winner in the Healthcare Sector?

Monday, November 27, 2023 11:46 AM | InvestorsObserver Analysts

Mentioned in this article

Is Ideaya Biosciences Inc (IDYA) a Winner in the Healthcare Sector?

The 93 rating InvestorsObserver gives to Ideaya Biosciences Inc (IDYA) stock puts it near the top of the Healthcare sector. In addition to scoring higher than 89 percent of stocks in the Healthcare sector, IDYA’s 93 overall rating means the stock scores better than 93 of all stocks.

Overall Score - 93
IDYA has an Overall Score of 93. Find out what this means to you and get the rest of the rankings on IDYA!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Ideaya Biosciences Inc Stock Today?

Ideaya Biosciences Inc (IDYA) stock is trading at $31.86 as of 11:34 AM on Monday, Nov 27, a decline of -$0.14, or -0.44% from the previous closing price of $32.00. The stock has traded between $31.22 and $31.99 so far today. Volume today is less active than usual. So far 116,377 shares have traded compared to average volume of 963,262 shares. Click Here to get the full Stock Report for Ideaya Biosciences Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App